34 results
8-K
EX-4.2
KTRA
Kintara Therapeutics Inc
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
EX-4.1
KTRA
Kintara Therapeutics Inc
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
EX-4.1
87l5p8a98 gd732c0b62
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-4.3
ugwz cyo4bfizj5iati
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-4.2
22icehh0x3cpp
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-4.1
63hsz
1 Sep 20
Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million
8:44am
8-K/A
EX-4.2
4ly3ivpoo04zt9hn
15 Aug 19
Delmar Pharmaceuticals Announces Pricing of $6.8 Million Underwritten Public Offering
12:00am
8-K/A
EX-4.3
zbz6wru6oavhz2g
15 Aug 19
Delmar Pharmaceuticals Announces Pricing of $6.8 Million Underwritten Public Offering
12:00am
8-K/A
EX-4.1
1so5q54pygh6ff 7emt
15 Aug 19
Delmar Pharmaceuticals Announces Pricing of $6.8 Million Underwritten Public Offering
12:00am
8-K/A
EX-4.4
vchk5
15 Aug 19
Delmar Pharmaceuticals Announces Pricing of $6.8 Million Underwritten Public Offering
12:00am